ArticleCPT: pharmacometrics & systems pharmacology2023

Prediction of relative change in free nerve growth factor following subcutaneous administration of tanezumab, a novel monoclonal antibody to nerve growth factor.

Satoshi Shoji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.